HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Electron transfer kinetics and mechanistic study of the thionicotinamide coordinated to the pentacyanoferrate(III)/(II) complexes: a model system for the in vitro activation of thioamides anti-tuberculosis drugs.

Abstract
The mechanism of activation thioamide-pyridine anti-tuberculosis prodrugs is poorly described in the literature. It has recently been shown that ethionamide, an important component of second-line therapy for the treatment of multi-drug-resistant tuberculosis, is activated through an enzymatic electron transfer (ET) reaction. In an attempt to shed light on the activation of thioamide drugs, we have mimicked a redox process involving the thionicotinamide (thio) ligand, investigating its reactivity through coordination to the redox reversible [Fe(III/II)(CN)(5)(H(2)O)](2-/3-) metal center. The reaction of the Fe(III) complex with thionicotinamide leads to the ligand conversion to the 3-cyanopyridine species coordinated to a Fe(II) metal center. The rate constant, k(et)=10 s(-1), was determined for this intra-molecular ET reaction. A kinetic study for the cross-reaction of thionicotinamide and [Fe(CN)(6)](3-) was also carried out. The oxidation of thionicotinamide by [Fe(CN)(6)](3-) leads to formation of mainly 3-cyanopyridine and [Fe(CN)(6)](4-) with a k(et)=(5.38+/-0.03) M(-1)s(-1) at 25 degrees C, pH 12.0. The rate of this reaction is strongly dependent on pH due to an acid-base equilibrium related to the deprotonation of the R-SH functional group of the imidothiol form of thionicotinamide. The kinetic results reinforced the assignment of an intra-molecular mechanism for the ET reaction of [Fe(III)(CN)(5)(H(2)O)](2-) and the thioamide ligand. These results can be valuable for the design of new thiocarbonyl-containing drugs against resistant strains of Mycobacterium tuberculosis by a self-activating mechanism.
AuthorsEduardo H S Sousa, Daniel L Pontes, Izaura C N Diógenes, Luiz G F Lopes, Jaim S Oliveira, Luiz A Basso, Diógenes S Santos, Icaro S Moreira
JournalJournal of inorganic biochemistry (J Inorg Biochem) Vol. 99 Issue 2 Pg. 368-75 (Feb 2005) ISSN: 0162-0134 [Print] United States
PMID15621268 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antitubercular Agents
  • Ferric Compounds
  • Ferrous Compounds
  • Prodrugs
  • pentacyanoferrate (III)
  • pentacyanoferrate (II)
  • Niacinamide
  • thionicotinamide
Topics
  • Antitubercular Agents (chemistry, metabolism)
  • Biotransformation
  • Drug Resistance, Multiple, Bacterial
  • Electron Transport
  • Ferric Compounds (chemistry, metabolism)
  • Ferrous Compounds (chemistry, metabolism)
  • Humans
  • In Vitro Techniques
  • Kinetics
  • Magnetic Resonance Spectroscopy
  • Molecular Structure
  • Mycobacterium tuberculosis (drug effects, metabolism)
  • Niacinamide (analogs & derivatives, chemistry, metabolism)
  • Oxidation-Reduction
  • Prodrugs (chemistry, metabolism)
  • Spectroscopy, Fourier Transform Infrared
  • Tuberculosis, Multidrug-Resistant (drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: